Similar to our research findings, Loharamtaweethong et al. also found PDL1 amplification, polyploidy of chromosome 9, and PDL1 protein overexpression in HIV-positive cervical cancer, which may also serve as a biomarker for prognosis of PD1/PDL1 therapy [42]. This evidence concerns the gene CD274 and cervical carcinoma.